High disease activity is associated with high disease damage in an Iranian inception cohort of patients with lupus nephritis

被引:0
|
作者
Shariati-Sarabi, Z. [1 ]
Monzavi, S. M. [2 ]
Ranjbar, A. [2 ]
Esmaily, H. [3 ]
Etemadrezaie, H. [4 ]
机构
[1] Mashhad Univ Med Sci, Sch Med, Dept Internal Med, Div Rheumatol, Mashhad, Iran
[2] Mashhad Univ Med Sci, Sch Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Mashhad, Iran
[4] Mashhad Univ Med Sci, Sch Med, Dept Neurosurg, Mashhad, Iran
关键词
SLEDAI; ECLAM; SDI; lupus nephritis; medication adherence; CONSENSUS-STUDY-GROUP; QUALITY-OF-LIFE; ACTIVITY INDEXES; SOCIOECONOMIC-STATUS; RHEUMATOLOGY RESEARCH; EUROPEAN WORKSHOP; RISK-FACTORS; ERYTHEMATOSUS; RACE; VALIDATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This paper aims to determine disease activity and damage in patients with lupus nephritis (LN) and to evaluate the correlation among these domains and sociodemographic features. Methods This study was carried out on 71 lupus patients who were candidate for kidney biopsy due to their clinical renal manifestations. Clinical and sociodemographic data were collected and the Systemic Lupus Erythaematosus Disease Activity Index (SLEDAI-2K updated version), European Consensus Lupus Activity Measurement (ECLAM) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) were assessed after 10 days of admission, the day prior to performing renal biopsy. Results Sixty-five females (91.5%) and six males (8.5%) were studied. Their age was 24 (21-32) yr and disease duration was 1.5 (0.8-4) yr (median [IQR]). SLEDAI-2K, ECLAM and SDI scores were 25.5 +/- 12.3, 6.21 +/- 2.45, 2.0 +/- 2.3 (mean +/- SD) respectively. A great relationship between SLEDAI-2K and ECLAM (r = 0.827, p<0.001) was found. SDI was significantly associated with SLEDAI-2K (r = 0.742, p<0.001) and ECLAM (r = 0.699, p<0.001). Age, gender and disease duration had no significant impact on SLEDAI-2K and ECLAM, while SDI was significantly higher in subjects with longer disease duration particularly in those of more than 3 years. Patients with lower education attainment had less medication adherence and higher disease activity and damage. Conclusion There is a highly significant correlation of high disease activity with cumulative damage in patients with LN, particularly in those with newly-onset disease. Considering that the first years of SLE are an active critical period which can lead to severe damage, this highlights the necessity of aggressive treatment, tight-organised follow-ups and more patient compliance with the physician orders.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 50 条
  • [1] High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis
    Faurschou, Mikkel
    Mellemkjaer, Lene
    Starklint, Henrik
    Kamper, Anne-Lise
    Tarp, Ulrik
    Voss, Anne
    Jacobsen, Soren
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (11) : 2400 - 2405
  • [2] Autoantibodies spectrum in lupus nephritis in a cohort of Egyptian patients: relation to disease activity and prognostic value
    Elsayed, Sahar A.
    Mohafez, Omar M. M.
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2020, 47 (01)
  • [3] Impact of anxiety and depression on disease activity and quality of life in patients with lupus nephritis
    Dadwal, Ritambra
    Pathak, Pragya
    Subbiah, Arunkumar
    Dahiya, Ujjwal
    INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 (04) : 460 - 464
  • [4] Joint trajectories of disease activity, and physical and mental health-related quality of life in an inception lupus cohort
    Fung, William
    Lim, Lily Siok Hoon
    Tomlinson, George
    Engel, Lisa
    Su, Jiandong
    Diaz-Martinez, Juan Pablo
    Touma, Zahi
    RHEUMATOLOGY, 2020, 59 (10) : 3032 - 3041
  • [5] Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort
    Lopez, Rekha
    Davidson, Julie E.
    Beeby, Matthew D.
    Egger, Peter J.
    Isenberg, David A.
    RHEUMATOLOGY, 2012, 51 (03) : 491 - 498
  • [6] Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis
    Kisaoglu, Hakan
    Baba, Ozge
    Kalyoncu, Mukaddes
    PEDIATRIC NEPHROLOGY, 2023, 38 (04) : 1167 - 1175
  • [7] Disease-specific quality of life in patients with lupus nephritis
    Jolly, M.
    Toloza, S.
    Goker, B.
    Clarke, A. E.
    Navarra, S. V.
    Wallace, D.
    Weisman, M.
    Mok, C. C.
    LUPUS, 2018, 27 (02) : 257 - 264
  • [8] Autoantibodies spectrum in lupus nephritis in a cohort of Egyptian patients: relation to disease activity and prognostic value
    Sahar A. Elsayed
    Omar M M. Mohafez
    Egyptian Rheumatology and Rehabilitation, 2020, 47
  • [9] Predictors of Chronic Kidney Disease in Korean Patients with Lupus Nephritis
    Moon, Su-Jin
    Kwok, Seung-Ki
    Ju, Ji Hyeon
    Park, Kyung-Su
    Park, Sung-Hwan
    Cho, Chul-Soo
    Kim, Ho-Youn
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (12) : 2588 - 2597
  • [10] Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study
    Kandane-Rathnayake, Rangi
    Golder, Vera
    Louthrenoo, Worawit
    Chen, Yi-Hsing
    Cho, Jiacai
    Lateef, Aisha
    Hamijoyo, Laniyati
    Luo, Shue-Fen
    Wu, Yeong-Jian J.
    Navarra, Sandra, V
    Zamora, Leonid
    Li, Zhanguo
    Sockalingam, Sargunan
    Katsumata, Yasuhiro
    Harigai, Masayoshi
    Hao, Yanjie
    Zhang, Zhuoli
    Basnayake, B. M. D. B.
    Chan, Madelynn
    Kikuchi, Jun
    Takeuchi, Tsutomu
    Bae, Sang-Cheol
    Oon, Sheeran
    O'Neill, Sean
    Goldblatt, Fiona
    Ng, Kristine
    Law, Annie
    Tugnet, Nicola
    Kumar, Sunil
    Tee, Cherica
    Tee, Michael
    Ohkubo, Naoaki
    Tanaka, Yoshiya
    Lau, Chak Sing
    Nikpour, Mandana
    Morand, Eric F.
    Hoi, Alberta
    Asia-Pacific Lupus Collaboration
    RHEUMATOLOGY, 2025,